Ricken, S.; Dietz-Terjung, S.; Weinreich, G.; Ortiz, J.; Schedel, M.; Straßburg, S.; Taube, C.; Welsner, M.; Bonella, F.; Sutharsan, S.
KL-6 as a Biomarker for Adult Patients with Cystic Fibrosis and the Impact of MUC1 Genotype. J. Clin. Med. 2026, 15, 4555.
https://doi.org/10.3390/jcm15124555
AMA Style
Ricken S, Dietz-Terjung S, Weinreich G, Ortiz J, Schedel M, Straßburg S, Taube C, Welsner M, Bonella F, Sutharsan S.
KL-6 as a Biomarker for Adult Patients with Cystic Fibrosis and the Impact of MUC1 Genotype. Journal of Clinical Medicine. 2026; 15(12):4555.
https://doi.org/10.3390/jcm15124555
Chicago/Turabian Style
Ricken, Sarah, Sarah Dietz-Terjung, Gerhard Weinreich, Jose Ortiz, Michaela Schedel, Svenja Straßburg, Christian Taube, Matthias Welsner, Francesco Bonella, and Sivagurunathan Sutharsan.
2026. "KL-6 as a Biomarker for Adult Patients with Cystic Fibrosis and the Impact of MUC1 Genotype" Journal of Clinical Medicine 15, no. 12: 4555.
https://doi.org/10.3390/jcm15124555
APA Style
Ricken, S., Dietz-Terjung, S., Weinreich, G., Ortiz, J., Schedel, M., Straßburg, S., Taube, C., Welsner, M., Bonella, F., & Sutharsan, S.
(2026). KL-6 as a Biomarker for Adult Patients with Cystic Fibrosis and the Impact of MUC1 Genotype. Journal of Clinical Medicine, 15(12), 4555.
https://doi.org/10.3390/jcm15124555
